ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

AMRN Amarin Corp PLC

0.9209
0.00 (0.00%)
プレマーケット
最終更新日: 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.9209 17:00:00
始値 安値 高値 終値 前日終値
0.9209
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2503:00GLOBEAmarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA..
2024/4/2221:00GLOBEAmarin Announces Results of Annual General Meeting of..
2024/4/1521:00GLOBEAmarin to Report First Quarter 2024 Financial Results and..
2024/4/0821:00GLOBEAmarin Highlights Key Data Providing Mechanistic Insights..
2024/4/0819:30PRNCANew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl)..
2024/4/0704:30GLOBENew REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent..
2024/4/0321:00GLOBEAmarin Provides Update on VAZKEPA® (Icosapent Ethyl)..
2024/3/2521:00GLOBEResearch Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent..
2024/3/0507:30EDGAR2Form ARS - Annual Report to Security Holders
2024/3/0422:00EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/2921:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2921:05EDGAR2Form 8-K - Current report
2024/2/2921:00GLOBEAmarin Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/1522:00GLOBEAmarin to Report Fourth Quarter and Full Year 2023 Financial..
2024/2/1222:00EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/1006:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2621:00EDGAR2Form 8-K - Current report
2024/1/2506:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2221:30GLOBEAmarin Chairman & CEO Issue Letter to Shareholders
2024/1/1307:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1307:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1307:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1021:00EDGAR2Form 8-K - Current report
2024/1/1021:00GLOBEAmarin Provides Preliminary Fourth Quarter 2023 Selected..
2024/1/0908:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0908:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1508:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1306:20EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1122:00GLOBEAmarin to Present at the 42nd Annual J.P. Morgan Healthcare..
2023/12/0606:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0521:30EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/1223:00GLOBENew REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl)..
2023/11/0405:30EDGAR2Form 8-K - Current report
2023/11/0120:05EDGAR2Form 8-K - Current report
2023/11/0120:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0120:00GLOBEAmarin Reports Third Quarter 2023 Financial Results
2023/11/0105:05EDGAR2Form 8-K - Current report
2023/11/0101:00GLOBEAmarin Appoints Jonathan Provoost Executive Vice President,..
2023/10/2621:00GLOBELatest Research Evaluating VASCEPA®/VAZKEPA® (icosapent..
2023/10/1921:00GLOBE Amarin to Report Third Quarter 2023 Financial Results and..
2023/9/1221:00GLOBEAmarin to Present at the 2023 Cantor Global Healthcare..
2023/9/0605:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/1708:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock